Abstract
Routine coagulation tests, such as PT and aPTT, are frequently abnormal in patients with chronic liver disease, but they usually fail to predict bleeding risk, leading to a liberal transfusional policy for prophylaxis, particularly before invasive procedures. Previous in vitro studies (none in vivo so far) have shown that prophylactic transfusion of fresh frozen plasma (FFP) in patients w…